236 related articles for article (PubMed ID: 25522766)
21. TDP1 and TOP1 as targets in anticancer treatment of NSCLC: Activity and protein level in normal and tumor tissue from 150 NSCLC patients correlated to clinical data.
Jakobsen AK; Yuusufi S; Madsen LB; Meldgaard P; Knudsen BR; Stougaard M
Lung Cancer; 2022 Feb; 164():23-32. PubMed ID: 34974222
[TBL] [Abstract][Full Text] [Related]
22. Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.
Jensen NF; Agama K; Roy A; Smith DH; Pfister TD; Rømer MU; Zhang HL; Doroshow JH; Knudsen BR; Stenvang J; Brünner N; Pommier Y
J Exp Clin Cancer Res; 2016 Mar; 35():56. PubMed ID: 27029323
[TBL] [Abstract][Full Text] [Related]
23. MUS81 cleaves TOP1-derived lesions and other DNA-protein cross-links.
Marini V; Nikulenkov F; Samadder P; Juul S; Knudsen BR; Krejci L
BMC Biol; 2023 May; 21(1):110. PubMed ID: 37194054
[TBL] [Abstract][Full Text] [Related]
24. Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes.
Miao ZH; Agama K; Sordet O; Povirk L; Kohn KW; Pommier Y
DNA Repair (Amst); 2006 Dec; 5(12):1489-94. PubMed ID: 16935573
[TBL] [Abstract][Full Text] [Related]
25. Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage.
Nitiss KC; Malik M; He X; White SW; Nitiss JL
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):8953-8. PubMed ID: 16751265
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.
Nguyen TX; Abdelmalak M; Marchand C; Agama K; Pommier Y; Cushman M
J Med Chem; 2015 Apr; 58(7):3188-208. PubMed ID: 25811317
[TBL] [Abstract][Full Text] [Related]
27. Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment.
Beretta GL; Cossa G; Gatti L; Zunino F; Perego P
Curr Med Chem; 2010; 17(15):1500-8. PubMed ID: 20166932
[TBL] [Abstract][Full Text] [Related]
28. Natural Products and Their Derivatives as Inhibitors of the DNA Repair Enzyme Tyrosyl-DNA Phosphodiesterase 1.
Zakharenko AL; Luzina OA; Chepanova AA; Dyrkheeva NS; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982848
[TBL] [Abstract][Full Text] [Related]
29. TDP1/TOP1 Ratio as a Promising Indicator for the Response of Small Cell Lung Cancer to Topotecan.
Meisenberg C; Ward SE; Schmid P; El-Khamisy SF
J Cancer Sci Ther; 2014 Jul; 6(7):258-267. PubMed ID: 25232464
[TBL] [Abstract][Full Text] [Related]
30. Studying TDP1 Function in DNA Repair.
Chiang SC; Liversidge K; El-Khamisy SF
Methods Mol Biol; 2018; 1703():173-181. PubMed ID: 29177742
[TBL] [Abstract][Full Text] [Related]
31. Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition.
Perego P; Cossa G; Tinelli S; Corna E; Carenini N; Gatti L; De Cesare M; Ciusani E; Zunino F; Luison E; Canevari S; Zaffaroni N; Beretta GL
Biochem Pharmacol; 2012 Jan; 83(1):27-36. PubMed ID: 21978643
[TBL] [Abstract][Full Text] [Related]
32. UCHL3 Regulates Topoisomerase-Induced Chromosomal Break Repair by Controlling TDP1 Proteostasis.
Liao C; Beveridge R; Hudson JJR; Parker JD; Chiang SC; Ray S; Ashour ME; Sudbery I; Dickman MJ; El-Khamisy SF
Cell Rep; 2018 Jun; 23(11):3352-3365. PubMed ID: 29898404
[TBL] [Abstract][Full Text] [Related]
33. Development of an oligonucleotide-based fluorescence assay for the identification of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors.
Walker S; Meisenberg C; Bibby RA; Askwith T; Williams G; Rininsland FH; Pearl LH; Oliver AW; El-Khamisy S; Ward S; Atack JR
Anal Biochem; 2014 Jun; 454(100):17-22. PubMed ID: 24637157
[TBL] [Abstract][Full Text] [Related]
34. Tyrosyl-DNA Phosphodiesterase 1 and Topoisomerase I Activities as Predictive Indicators for Glioblastoma Susceptibility to Genotoxic Agents.
Wang W; Rodriguez-Silva M; Acanda de la Rocha AM; Wolf AL; Lai Y; Liu Y; Reinhold WC; Pommier Y; Chambers JW; Tse-Dinh YC
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31547492
[TBL] [Abstract][Full Text] [Related]
35. TDP1 knockout Leishmania donovani accumulate topoisomerase 1-linked DNA damage and are hypersensitive to clinically used antileishmanial drugs.
Chowdhury SR; Das SK; Banerjee B; Paul Chowdhuri S; Majumder HK; Das BB
FASEB J; 2022 Apr; 36(4):e22265. PubMed ID: 35319800
[TBL] [Abstract][Full Text] [Related]
36. Mutation of a conserved active site residue converts tyrosyl-DNA phosphodiesterase I into a DNA topoisomerase I-dependent poison.
He X; van Waardenburg RCAM; Babaoglu K; Price AC; Nitiss KC; Nitiss JL; Bjornsti MA; White SW
J Mol Biol; 2007 Sep; 372(4):1070-1081. PubMed ID: 17707402
[TBL] [Abstract][Full Text] [Related]
37. TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo.
Katyal S; el-Khamisy SF; Russell HR; Li Y; Ju L; Caldecott KW; McKinnon PJ
EMBO J; 2007 Nov; 26(22):4720-31. PubMed ID: 17914460
[TBL] [Abstract][Full Text] [Related]
38. TDP1 and PARP1 deficiency are cytotoxic to rhabdomyosarcoma cells.
Fam HK; Walton C; Mitra SA; Chowdhury M; Osborne N; Choi K; Sun G; Wong PC; O'Sullivan MJ; Turashvili G; Aparicio S; Triche TJ; Bond M; Pallen CJ; Boerkoel CF
Mol Cancer Res; 2013 Oct; 11(10):1179-92. PubMed ID: 23913164
[TBL] [Abstract][Full Text] [Related]
39. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1.
El-Khamisy SF; Saifi GM; Weinfeld M; Johansson F; Helleday T; Lupski JR; Caldecott KW
Nature; 2005 Mar; 434(7029):108-13. PubMed ID: 15744309
[TBL] [Abstract][Full Text] [Related]
40. TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II.
Barthelmes HU; Habermeyer M; Christensen MO; Mielke C; Interthal H; Pouliot JJ; Boege F; Marko D
J Biol Chem; 2004 Dec; 279(53):55618-25. PubMed ID: 15494395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
